About ETS domain-containing protein Elk-4
ETS domain-containing protein Elk-4 (ELK4) is a protein
from Homo sapiens identified by UniProt accession
P28324, 431 residues long.
MolForge cross-references it against 0 known binders and
189 disease associations.
Target properties
| Protein name | ETS domain-containing protein Elk-4 |
| UniProt accession | P28324 |
| Gene | ELK4 |
| Organism | Homo sapiens |
| Length | 431 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (189)
Diseases linked to this target (Open Targets).
- bile duct carcinoma · score 0.37
- prostate adenocarcinoma · score 0.37
- carcinoma of liver and intrahepatic biliary tract · score 0.37
- skin basal cell carcinoma · score 0.37
- neurodegenerative disease · score 0.37
- hepatocellular carcinoma · score 0.29
- melanoma · score 0.29
- esophageal squamous cell carcinoma · score 0.28
- urinary bladder carcinoma · score 0.28
- pancreatic ductal adenocarcinoma · score 0.28
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P28324-F1 | alphafold | PREDICTED | 59.03 | — |
Amino-acid sequence (431 residues)
MDSAITLWQF LLQLLQKPQN KHMICWTSND GQFKLLQAEE VARLWGIRKN KPNMNYDKLS RALRYYYVKN IIKKVNGQKF VYKFVSYPEI LNMDPMTVGR IEGDCESLNF SEVSSSSKDV ENGGKDKPPQ PGAKTSSRND YIHSGLYSSF TLNSLNSSNV KLFKLIKTEN PAEKLAEKKS PQEPTPSVIK FVTTPSKKPP VEPVAATISI GPSISPSSEE TIQALETLVS PKLPSLEAPT SASNVMTAFA TTPPISSIPP LQEPPRTPSP PLSSHPDIDT DIDSVASQPM ELPENLSLEP KDQDSVLLEK DKVNNSSRSK KPKGLELAPT LVITSSDPSP LGILSPSLPT ASLTPAFFSQ TPIILTPSPL LSSIHFWSTL SPVAPLSPAR LQGANTLFQF PSVLNSHGPF TLSGLDGPST PGPFSPDLQK T
Explore ETS domain-containing protein Elk-4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets